AMBA vs ALAB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ALAB Captures Institutional Edge (2โ2 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Astera Labs, Inc. Common Stock (ALAB) driven by superior Growth & Margin, Momentum & Technical while AMBA counters with relative strength in Valuation, Options & Structure. Fundamentally, AMBA trades at 88.6x Forward P/E with -14.9% operating margin (+13.2% YoY revenue) versus ALAB at 29.9x Forward P/E and 25.5% operating margin (+153.7% YoY). In options structure, AMBA sits in BREAKDOWN (21st %ile IV; Dealer Gamma Walls on Pro) against ALAB sits in BREAKDOWN (70th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AMBA Revenue | ALAB Revenue | AMBA Op. Margin | ALAB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $230M | N/A | -17.7% | N/A | AMBA |
| FY2020 | $230M | N/A | -21.7% | N/A | AMBA |
| FY2021 | $220M | N/A | -27.4% | N/A | AMBA |
| FY2022 | $330M | $80M | -8.9% | -75.4% | AMBA |
| FY2023 | $340M | $120M | -22.0% | -25.5% | AMBA |
| FY2024 | $230M | $400M | -68.2% | -29.3% | ALAB |
| FY2025 | $280M | $850M | -44.4% | 20.3% | ALAB |
| FY2026 | $390M | N/A | -21.1% | N/A | AMBA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AMBA | ALAB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.4B | $37.9B | Larger Scale | ALAB |
| Trailing P/E Ratio Valuation | 51.0x | 85.7x | Lower Multiple | AMBA |
| Forward P/E Ratio Valuation | 88.6x | 29.9x | Lower Multiple | ALAB |
| Revenue Growth (YoY) Growth | +13.2% | +153.7% | Higher Growth | ALAB |
| Operating Margin (TTM) Profitability | -14.9% | 25.5% | Higher Margin | ALAB |
| Net Profit Margin Profitability | -13.5% | 29.6% | Higher Margin | ALAB |
| Return on Equity (ROE) Capital Efficiency | -9.4% | 28.2% | Higher ROE | ALAB |
| 52-Week Range Position Momentum | 22% ($48โ$96) | 28% ($98โ$499) | Stronger Trend | ALAB |
| Beta / 30D Volatility Risk Regime | 2.44ฮฒ ยท 70% Vol | 4.15ฮฒ ยท 123% Vol | Lower Realized Risk | AMBA |
| Unified Institutional Score Composite Signal | 56.1 / 100 (HOLD) | 59.4 / 100 (HOLD) | Higher Composite | ALAB |